Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Glycine Augmentation in GLDC Mutation Carriers
NCT01720316Phase 2Completed
- Sponsor
- McLean Hospital
- Start
- Dec 2012
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycine in schizoaffective disorder, bipolar disorder (BD), sponsored by McLean Hospital. Started Dec 2012; status: completed.
02
Drugs
glycine
03
Conditions
schizoaffective disorderbipolar disorder (BD)
Beyond the preview
Go deeper on NCT01720316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720316.